Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home) (QS210)Product type:Quality standardPublished: 31 October 2023
Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: the DYSIS colposcope with DYSISmap and the ZedScan I (DG32)Product type:GuidanceProgramme:Diagnostics guidancePublished: 25 April 2018
AI-derived computer-aided detection (CAD) software for detecting and measuring lung nodules in CT scan images (DG55)Product type:GuidanceProgramme:Diagnostics guidancePublished: 5 July 2023
AI in retinal scanning MT524 (MIB265)Status:Topic selectionProgramme:Medical technologies guidanceExpected publication date: TBC
AposHealth for knee osteoarthritis (MTG76)Product type:GuidanceProgramme:Medical technologies guidancePublished: 11 April 2023
Artificial intelligence (AI)-derived software to help clinical decision making in stroke (DG57)Product type:GuidanceProgramme:Diagnostics guidanceLast updated: 2 May 2024Published: 23 January 2024
Artificial intelligence (AI) technologies for assessing and triaging skin lesions within the urgent suspected skin cancer pathwayStatus:In developmentProgramme:Health technology evaluationExpected publication date: 19 December 2024
Artificial intelligence-derived software to analyse chest X-rays for suspected lung cancer in primary care referrals: early value assessment (HTE12)Product type:GuidanceProgramme:Health technology evaluationPublished: 28 September 2023
Artificial intelligence software to help detect and characterise colorectal polypsStatus:In developmentProgramme:Diagnostics guidanceExpected publication date: TBC
Artificial intelligence technologies to aid contouring for radiotherapy treatment planning: early value assessment (HTE11)Product type:GuidanceProgramme:Health technology evaluationPublished: 27 September 2023
Artificial intelligence technologies to help detect fractures on X-rays in urgent careStatus:In developmentProgramme:Health technology evaluationExpected publication date: 14 January 2025
Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system) (DG14)Product type:GuidanceProgramme:Diagnostics guidanceLast updated: 19 December 2017Published: 24 September 2014
Automated ankle brachial pressure index measurement devices to detect peripheral arterial disease in people with leg ulcers (DG52)Product type:GuidanceProgramme:Diagnostics guidancePublished: 24 May 2023
Biomarker tests to help diagnose preterm labour in women with intact membranes (DG33)Product type:GuidanceProgramme:Diagnostics guidancePublished: 4 July 2018
CaRi-Heart for predicting cardiac risk in suspected coronary artery disease: early value assessment (HTE4)Product type:GuidanceProgramme:Health technology evaluationPublished: 9 March 2023
COLOFIT algorithm to guide colorectal cancer pathway referral in primary care: early value assessmentStatus:In developmentProgramme:Health technology evaluationExpected publication date: TBC
Computed tomographic colonography (virtual colonoscopy) (IPG129)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 22 June 2005
Depth of anaesthesia monitors – Bispectral Index (BIS), E-Entropy and Narcotrend-Compact M (DG6)Product type:GuidanceProgramme:Diagnostics guidancePublished: 21 November 2012
Detecting, managing and monitoring haemostasis: viscoelastometric point‑of‑care testing (ROTEM, TEG and Sonoclot systems) (DG13)Product type:GuidanceProgramme:Diagnostics guidancePublished: 20 August 2014
Devices for remote monitoring of Parkinson’s disease (DG51)Product type:GuidanceProgramme:Diagnostics guidanceLast updated: 25 January 2024Published: 25 January 2023
Digital health technologies to help manage symptoms of psychosis and prevent relapse in adults and young people: early value assessment (HTE17)Product type:GuidanceProgramme:Health technology evaluationPublished: 25 March 2024
Digitally enabled therapies for adults with anxiety disorders: early value assessment (HTE9)Product type:GuidanceProgramme:Health technology evaluationLast updated: 14 December 2023Published: 16 May 2023
Digitally enabled therapies for adults with depression: early value assessment (HTE8)Product type:GuidanceProgramme:Health technology evaluationLast updated: 12 February 2024Published: 16 May 2023
Digital platforms for community based self-management of mild to moderate osteoarthritis and joint pain: Early value assessmentStatus:Awaiting developmentProgramme:Health technology evaluationExpected publication date: TBC
Digital platforms to support cardiac rehabilitationStatus:Awaiting developmentProgramme:Health technology evaluationExpected publication date: TBC
Digital platforms to support self-management of asthma : early value assessmentStatus:Awaiting developmentProgramme:Health technology evaluationExpected publication date: TBC
Digital support for children and young people with eating disorders:early value assessmentStatus:Awaiting developmentProgramme:Health technology evaluationExpected publication date: TBC
Digital technologies for delivering multidisciplinary weight-management services: early value assessment (HTE14)Product type:GuidanceProgramme:Health technology evaluationLast updated: 6 March 2024Published: 26 October 2023
Digital technologies for managing non-specific low back pain: early value assessment (HTE16)Product type:GuidanceProgramme:Health technology evaluationPublished: 5 March 2024
Digital technologies to deliver pulmonary rehabilitation programmes for adults with COPD: early value assessment (HTE18)Product type:GuidanceProgramme:Health technology evaluationPublished: 30 April 2024
Digital technologies to support self-management of COPD: early value assessmentStatus:In developmentProgramme:Health technology evaluationExpected publication date: 19 December 2024
Digital technologies to support smoking cessation in secondary care patients: early value assessmentStatus:Awaiting developmentProgramme:Health technology evaluationExpected publication date: TBC
Digital therapy for chronic tic disorders and Tourette syndrome: early value assessmentStatus:In development | In consultationProgramme:Health technology evaluationConsultation end date: 17 December 2024Expected publication date: 24 April 2025
EGFR‑TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer (DG9)Product type:GuidanceProgramme:Diagnostics guidancePublished: 14 August 2013
FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care (DG48)Product type:GuidanceProgramme:Diagnostics guidancePublished: 7 June 2023
Fluorouracil chemotherapy: The My5‑FU assay for guiding dose adjustment (DG16)Product type:GuidanceProgramme:Diagnostics guidancePublished: 10 December 2014
GaitSmart rehabilitation exercise programme for gait and mobility issues (MTG78)Product type:GuidanceProgramme:Medical technologies guidancePublished: 3 April 2024
gammaCore for cluster headache (MTG46)Product type:GuidanceProgramme:Medical technologies guidancePublished: 3 December 2019
Genedrive MT-RNR1 ID Kit for detecting a genetic variant to guide antibiotic use and prevent hearing loss in babies: early value assessment (HTE6)Product type:GuidanceProgramme:Health technology evaluationLast updated: 10 August 2023Published: 30 March 2023
Guided self-help digital cognitive behavioural therapy for children and young people with mild to moderate symptoms of anxiety or low mood: early value assessment (HTE3)Product type:GuidanceProgramme:Health technology evaluationLast updated: 5 September 2023Published: 8 February 2023
Heart failure algorithms for remote monitoring in people with cardiac implantable electronic devices (DG61)Product type:GuidanceProgramme:Diagnostics guidancePublished: 24 October 2024
HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography (MTG32)Product type:GuidanceProgramme:Medical technologies guidanceLast updated: 19 May 2021Published: 13 February 2017
High-sensitivity troponin tests for the early rule out of NSTEMI (DG40)Product type:GuidanceProgramme:Diagnostics guidancePublished: 26 August 2020
High-throughput non-invasive prenatal testing for fetal RHD genotype (DG25)Product type:GuidanceProgramme:Diagnostics guidancePublished: 9 November 2016
ImmunoCAP ISAC 112 for multiplex allergen testing (DG24)Product type:GuidanceProgramme:Diagnostics guidancePublished: 18 May 2016
Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke (DG41)Product type:GuidanceProgramme:Diagnostics guidancePublished: 2 September 2020
Intraoperative tests (RD‑100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancer (DG8)Product type:GuidanceProgramme:Diagnostics guidancePublished: 7 August 2013
KardiaMobile 6L for measuring cardiac QT interval in adults having antipsychotic medication (HTE10)Product type:GuidanceProgramme:Health technology evaluationPublished: 26 September 2023
KardiaMobile for detecting atrial fibrillation (MTG64)Product type:GuidanceProgramme:Medical technologies guidanceLast updated: 25 July 2023Published: 6 January 2022
Lead-I ECG devices for detecting symptomatic atrial fibrillation using single time point testing in primary care (DG35)Product type:GuidanceProgramme:Diagnostics guidancePublished: 8 May 2019
Magtrace and Sentimag system for locating sentinel lymph nodes for breast cancer (MTG72)Product type:GuidanceProgramme:Medical technologies guidancePublished: 5 October 2022
Magtrace/Sentimag MT599 (MIB263)Status:Topic selectionProgramme:Medical technologies guidanceExpected publication date: TBC
Molecular testing strategies for Lynch syndrome in people with colorectal cancer (DG27)Product type:GuidanceProgramme:Diagnostics guidancePublished: 22 February 2017
MRI-based technologies for assessing non-alcoholic fatty liver disease (DG50)Product type:GuidanceProgramme:Diagnostics guidancePublished: 12 January 2023
MRI fusion biopsy systems for diagnosing prostate cancer (DG53)Product type:GuidanceProgramme:Diagnostics guidancePublished: 24 May 2023
MT656 Paige Prostate AI system for the detection of prostate cancerStatus:Topic selectionProgramme:Diagnostics guidanceExpected publication date: TBC
Multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis (DG29)Product type:GuidanceProgramme:Diagnostics guidancePublished: 21 June 2017
myCOPD for managing chronic obstructive pulmonary disease (MTG68)Product type:GuidanceProgramme:Medical technologies guidancePublished: 31 March 2022
New generation cardiac CT scanners (Aquilion ONE, Brilliance iCT, Discovery CT750 HD and Somatom Definition Flash) for cardiac imaging in people with suspected or known coronary artery disease in whom imaging is difficult with earlier generation CT scanners (DG3)Product type:GuidanceProgramme:Diagnostics guidanceLast updated: 6 July 2017Published: 25 January 2012
PLGF-based testing to help diagnose suspected preterm pre-eclampsia (DG49)Product type:GuidanceProgramme:Diagnostics guidancePublished: 27 July 2022
Point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast (DG37)Product type:GuidanceProgramme:Diagnostics guidancePublished: 13 November 2019
Procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay) (DG18)Product type:GuidanceProgramme:Diagnostics guidancePublished: 7 October 2015
ProKnow cloud-based system for radiotherapy data storage, communication and management: early value assessment (HTE5)Product type:GuidanceProgramme:Health technology evaluationLast updated: 14 March 2024Published: 28 March 2023
QAngio XA 3D QFR and CAAS vFFR imaging software for assessing coronary stenosis during invasive coronary angiography (DG43)Product type:GuidanceProgramme:Diagnostics guidancePublished: 17 March 2021
Rapid tests for group A streptococcal infections in people with a sore throat (DG38)Product type:GuidanceProgramme:Diagnostics guidancePublished: 13 November 2019
SepsiTest assay for rapidly identifying bloodstream bacteria and fungi (DG20)Product type:GuidanceProgramme:Diagnostics guidanceLast updated: 19 February 2020Published: 10 February 2016
Sleepio to treat insomnia and insomnia symptoms (MTG70)Product type:GuidanceProgramme:Medical technologies guidancePublished: 20 May 2022
Testing strategies for Lynch syndrome in people with endometrial cancer (DG42)Product type:GuidanceProgramme:Diagnostics guidancePublished: 28 October 2020
Tests in secondary care to identify people at high risk of ovarian cancer (DG31)Product type:GuidanceProgramme:Diagnostics guidancePublished: 15 November 2017
Tests to help assess risk of acute kidney injury for people being considered for critical care admission (ARCHITECT and Alinity i Urine NGAL assays, BioPorto NGAL test and NephroCheck test) (DG39)Product type:GuidanceProgramme:Diagnostics guidancePublished: 17 June 2020
The EOS 2D/3D imaging system (DG1)Product type:GuidanceProgramme:Diagnostics guidancePublished: 26 October 2011
Therapeutic monitoring of TNF-alpha inhibitors in Crohn’s disease (LISA-TRACKER ELISA kits, IDKmonitor ELISA kits, and Promonitor ELISA kits) (DG22)Product type:GuidanceProgramme:Diagnostics guidancePublished: 17 February 2016
Therapeutic monitoring of TNF-alpha inhibitors in rheumatoid arthritis (DG36)Product type:GuidanceProgramme:Diagnostics guidancePublished: 10 July 2019
Thopaz+ portable digital system for managing chest drains (MTG37)Product type:GuidanceProgramme:Medical technologies guidanceLast updated: 6 June 2022Published: 21 March 2018
Virtual chromoendoscopy to assess colorectal polyps during colonoscopy (DG28)Product type:GuidanceProgramme:Diagnostics guidancePublished: 10 May 2017
Virtual reality technologies for treating agoraphobia or agoraphobic avoidance: early value assessment (HTE15)Product type:GuidanceProgramme:Health technology evaluationPublished: 15 November 2023
Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C (MTG27)Product type:GuidanceProgramme:Medical technologies guidanceLast updated: 17 January 2020Published: 23 September 2015
Virtual ward platform technologies for acute respiratory infections (HTE13)Product type:GuidanceProgramme:Health technology evaluationPublished: 12 October 2023
Virtual Wards for COPD exacerbationsStatus:Awaiting developmentProgramme:Medical technologies guidanceExpected publication date: TBC
Virtual Wards for Heart FailureStatus:Awaiting developmentProgramme:Medical technologies guidanceExpected publication date: TBC
VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesions (DG19)Product type:GuidanceProgramme:Diagnostics guidancePublished: 11 November 2015
Zio XT for detecting cardiac arrhythmias (MTG52)Product type:GuidanceProgramme:Medical technologies guidancePublished: 1 December 2020